CSF3 and diffuse large B-cell lymphoma: The present study aims to determine the prevalence of FN after R-CHOP-21 in patients with newly diagnosed DLBCL and to assess the impact of primary prophylaxis with G-CSF on FN, as well as other clinical outcomes such as septic shock, death, and dose reduction.